|
||||||||||||||||||||||
![]() |
|
|
|
![]() |
Alternate Title Phase I/II Randomized Pilot Study of CD-ROM Education Versus Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer
Trial Description The use of a CD-ROM may help patients with colorectal cancer or a family history of colorectal cancer make informed decisions about undergoing microsatellite instability (MSI) testing. This randomized phase I/II trial is studying an educational CD-ROM to see how well it works compared with standard informed consent to assist decision-making about MSI testing in patients with colorectal cancer or a family history of colorectal cancer. Eligibility criteria include the following:
Final eligibility for a clinical trial is determined by the health professionals conducting the trial. Some patients will receive an educational CD-ROM and will give feedback on the information it provides and its usefulness. Other patients will be randomly assigned (have an equal chance of being placed) to one of two groups. Patients in group one will be interviewed. They will also receive an informed consent for MSI testing and a standard explanation about the test. Patients in group two will be interviewed. They will also receive an informed consent for MSI testing, and an educational CD-ROM that explains the test. Patients in groups one and two will fill out a survey at 2 weeks. Patients will undergo tissue sample collection for genetic testing. Important: For more details about this trial, refer to the Health Professional version of the trial summary. If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site. Trial Lead Organizations Fox Chase Cancer Center - Philadelphia
|
![]() |
![]() |
![]() |
![]() |
NCI Home |
Images Version |
Contact Us |
Policies |
Accessibility |
Viewing Files |
FOIA |
Site Help |
Site Map
|
![]() A Service of the National Cancer Institute |
![]() |
![]() |